Opportunity Information: Apply for PAR 19 297
Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional), Funding Opportunity Number PAR 19-297, is a National Institutes of Health (NIH) discretionary grant opportunity designed to support collaborative, multi-site clinical studies focused on understanding mental illnesses rather than testing new treatments. The central idea is to fund research that can answer important clinical and mechanistic questions about mental health by bringing together two or more research sites under a shared, single protocol. This multi-site structure is meant to make studies stronger and more generalizable by increasing total sample size, speeding up recruitment, and improving participant diversity and representation across different communities and settings.
The scientific scope emphasizes clinical studies in areas such as mental health genetics, biomarker discovery or validation, and deeper characterization of mental illnesses. Examples include research on psychopathology and the ways symptoms present and change across individuals, as well as studies of neurodevelopmental trajectories that track how risk, symptoms, and related biological or behavioral measures evolve over time. The announcement also highlights that studies may address mental illnesses in the context of HIV/AIDS, recognizing that mental health conditions can intersect with HIV-related factors and outcomes in clinically meaningful ways. While the FOA allows clinical trials to be optional, it is explicit that the purpose is not treatment development and not efficacy or effectiveness testing; in other words, this is not the right mechanism for projects whose primary goal is to determine whether an intervention works.
A defining feature of this opportunity is the expectation of true collaboration across sites. Applicants are expected to use a common protocol and aligned methods across participating locations so that data can be pooled and compared cleanly. When a project involves many sites, NIH expects that one application will function as a coordinating R01, responsible for centralized duties such as data management and other administrative coordination needed to keep the overall study consistent and on track. This coordinating structure is intended to reduce fragmentation, maintain data quality, and ensure that all sites adhere to the same study procedures, measures, and governance.
Eligibility is broad and includes many types of organizations that can carry out clinical research. In addition to standard applicants such as public and private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses) and small businesses, and multiple levels of government (state, county, city/township, special district, and independent school districts), the FOA explicitly includes tribal entities and housing authorities as eligible applicants. It also calls out a wide range of additional eligible applicants and partner-ready institutions, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. Notably, non-domestic (non-U.S.) entities (foreign organizations) are also listed among eligible applicants, which can support international collaboration when scientifically justified.
From an administrative standpoint, the award mechanism is the NIH R01 research project grant, categorized under Health, with CFDA number 93.242. The FOA was created on 2019-06-10, and the original closing date listed in the source information is 2022-09-07. The source data does not specify an award ceiling or the expected number of awards, so applicants typically would look to NIH institute guidance, budget justification norms for R01s, and the specific scientific and operational needs of a multi-site study when planning project scope and budget.
Overall, this opportunity is aimed at teams that need a coordinated, multi-site approach to answer clinically relevant questions about mental illness using shared protocols, with particular encouragement for work in genetics, biomarkers, and developmental or phenomenological studies of psychopathology, including when mental health conditions intersect with HIV/AIDS. The best fit projects are those where collaboration is essential to achieve adequate sample size, recruitment speed, or representation, and where the primary goal is to generate robust clinical and biological knowledge rather than to test whether a treatment works.Apply for PAR 19 297
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2019-06-10.
- Applicants must submit their applications by 2022-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Port Infrastructure Development Grants
Previous opportunity: FY19 ATC PLC Youth Corps Projects
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 297
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 297) also looked into and applied for these:
| Funding Opportunity |
|---|
| Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional) Apply for RFA AG 20 022 Funding Number: RFA AG 20 022 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders (U24 Clinical Trial Not Allowed) Apply for RFA MH 20 215 Funding Number: RFA MH 20 215 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 Clinical Trial Not Allowed) Apply for RFA NS 19 039 Funding Number: RFA NS 19 039 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed) Apply for RFA AG 20 007 Funding Number: RFA AG 20 007 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) Apply for PAR 19 298 Funding Number: PAR 19 298 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate (T34) Apply for PAR 19 299 Funding Number: PAR 19 299 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Country Health Information Systems and Data Use (CHISU) Apply for 7200AA19R00065 Funding Number: 7200AA19R00065 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) Apply for PAR 19 300 Funding Number: PAR 19 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Centers for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 009 Funding Number: RFA RM 19 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Network Hub for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 010 Funding Number: RFA RM 19 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 039 Funding Number: RFA AG 20 039 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 19 302 Funding Number: PAR 19 302 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 19 301 Funding Number: PAR 19 301 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 20 018 Funding Number: RFA AG 20 018 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional) Apply for RFA AG 20 028 Funding Number: RFA AG 20 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Apply for PAR 19 304 Funding Number: PAR 19 304 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Apply for PAR 19 305 Funding Number: PAR 19 305 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 042 Funding Number: RFA AG 20 042 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 300 Funding Number: RFA MH 20 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed) Apply for RFA NS 19 040 Funding Number: RFA NS 19 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 297", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
